FibroGen Inc - Company Profile
Powered by
All the data and insights you need on FibroGen Inc in one report.
- Save hours of research time and resources with
our up-to-date FibroGen Inc Strategy Report
- Understand FibroGen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
FibroGen Inc (FibroGen) is a biopharmaceutical company that discovers, develops, and commercializes medicines based on hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology for addressing the unmet medical needs of anemia in chronic kidney disease and idiopathic pulmonary fibrosis. Focus on R&D, the lead product candidate: Roxadustat and geographic presence are its strengths even as history of operating losses could be a major cause for concern for the company. FibroGen could benefit from rising healthcare expenditures in the us, market potential: cystic fibrosis and market potential of rare diseases and orphan drugs. However, dependence on third-party manufacturers, stiff competition, and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer